[Oral anticoagulants in the elderly].

No abstract is available for this paper.

• Publication year

  2003

• Venue

  La Revue de medecine interne

• Publication date

  2003-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0248-8663(02)00020-6PMID 12650892
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessing the nutritional status of the elderly: The Mini Nutritional Assessment as part of the geriatric evaluation.

  2009cited by this paper
• Risques hémorragiques des anti-vitamines K au cours de la maladie thrombo-embolique veineuse

  2002cited by this paper
• [Risk of hemorrhage with oral anticoagulants for deep vein thrombosis].

  2002cited by this paper
• How we diagnose and treat deep vein thrombosis.

  2002cited by this paper
• Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.

  2001cited by this paper
• [Oral anticoagulation in older patients. Establishment and validation of a new posologic warfarin regimen].

  2001cited by this paper
• Durée du traitement anticoagulant oral dans la maladie thromboembolique veineuse * 1 1 Étude réalisée avec le soutien du conseil scientifique de la SNFMI.

  2001cited by this paper
• Antithrombotic therapy for venous thromboembolic disease.

  2001cited by this paper
• Characteristics of Anticoagulant Therapy and Comorbidity Related to Overanticoagulation

  2001cited by this paper
• Hemorrhagic complications of anticoagulant treatment.

  2001cited by this paper
• The Epidemiology of Venous Thromboembolism in the Community

  2001cited by this paper
• Oral anticoagulants: Pharmacologic issues for use in the elderly

  2001cited by this paper
• New anticoagulant drugs.

  2001cited by this paper
• Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.

  2001cited by this paper
• [Duration of oral anticoagulant therapy in venous thromboembolism].

  2001cited by this paper
• Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study.

  2001cited by this paper
• Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.

  2001cited by this paper
• Antithrombotic therapy in atrial fibrillation.

  2001cited by this paper
• Utilisation des antivitamines K en pratique médicale courante

  2000cited by this paper
• Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study.

  2000cited by this paper
• A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial.

  2000cited by this paper
• A Multicomponent Intervention To Prevent Major Bleeding Complications in Older Patients Receiving Warfarin

  2000cited by this paper
• A comparison of a low-dose warfarin induction regimen with the modified Fennerty regimen in elderly inpatients.

  2000cited by this paper
• Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation.

  2000cited by this paper
• Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment.

  2000cited by this paper
• Anticoagulation to prevent stroke in atrial fibrillation. Comprehensive geriatric evaluation should be routine before treatment is started.

  2000cited by this paper
• Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness

  2000cited by this paper
• Geriatric assessment and anticoagulation in elderly patients with chronic atrial fibrillation.

  2000cited by this paper
• Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation : a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group.

  2000cited by this paper
• Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis.

  1999cited by this paper
• Comparison of an age adjusted warfarin loading protocol with empirical dosing and Fennerty's protocol.

  1999cited by this paper
• Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism.

  1999cited by this paper
• Treatment for the Secondary Prevention of Stroke in Older Patients: The Influence of Dementia Status

  1999cited by this paper
• Major bleeding after hospitalization for deep-venous thrombosis.

  1999cited by this paper
• Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation

  1999cited by this paper
• A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

  1999cited by this paper
• A randomized trial comparing 5-mg and 10-mg warfarin loading doses.

  1999cited by this paper
• Prevalence of atrial fibrillation and eligibility for anticoagulants in the community.

  1998cited by this paper
• Out-patient treatment of acute deep vein thrombosis.

  1998cited by this paper
• Antidepressant interactions with warfarin

  1998cited by this paper
• Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation.

  1998cited by this paper
• Multicentre randomised study of computerised anticoagulant dosage. European Concerted Action on Anticoagulation.

  1998cited by this paper
• Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs.

  1998cited by this paper
• Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin.

  1998cited by this paper
• One‐Leg Balance Is an Important Predictor of Injurious Falls in Older Persons

  1997cited by this paper
• Warfarin-Related Bleeding in the Elderly

  1997cited by this paper
• Is warfarin underused in the treatment of elderly persons with atrial fibrillation?

  1997cited by this paper
• Thrombotic Events during Oral Anticoagulant Treatment: Results of the Inception-cohort, Prospective, Collaborative ISCOAT Study

  1997cited by this paper
• The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.

  1997cited by this paper
• Comparison of 5-mg and 10-mg Loading Doses in Initiation of Warfarin Therapy

  1997cited by this paper
• An Evaluation and Improvement Program for Inpatient Anticoagulant Control

  1997cited by this paper
• Warfarin use among patients with atrial fibrillation.

  1997cited by this paper
• The Risk for and Severity of Bleeding Complications in Elderly Patients Treated with Warfarin

  1996cited by this paper
• Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.

  1996cited by this paper
• An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.

  1996cited by this paper
• Rebound after cessation of oral anticoagulant therapy: the biochemical evidence

  1996cited by this paper
• Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial.

  1996cited by this paper
• Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.

  1996cited by this paper
• Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy.

  1996cited by this paper
• AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves.

  1996cited by this paper
• Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)

  1996cited by this paper
• Prescriber guidelines improve initiation of anticoagulation

  1995cited by this paper
• Optimal oral anticoagulant therapy in patients with mechanical heart valves.

  1995cited by this paper
• Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.

  1994cited by this paper
• Risk Factors for Complications of Chronic Anticoagulation: A Multicenter Study

  1993cited by this paper
• Comprehensive geriatric assessment: a meta-analysis of controlled trials.

  1993cited by this paper
• Bleeding complications in oral anticoagulant therapy. An analysis of risk factors.

  1993cited by this paper
• Bleeding complications in oral anticoagulant therapy : an analysis of risk factors

  1993cited by this paper
• Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention.

  1993cited by this paper
• Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.

  1992cited by this paper
• Hemorrhagic complications of anticoagulant treatment.

  1992cited by this paper
• The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons

  1991cited by this paper
• The association of age with dosage requirement for warfarin.

  1991cited by this paper
• Antithrombotic therapy for venous thromboembolic disease.

  1989cited by this paper
• Age-related risks of long-term oral anticoagulant therapy.

  1988cited by this paper
• Balance in elderly patients: the "get-up and go" test.

  1986cited by this paper
• Performance‐Oriented Assessment of Mobility Problems in Elderly Patients

  1986cited by this paper
• Flexible induction dose regimen for warfarin and prediction of maintenance dose.

  1984cited by this paper
• The Mini-Mental State Examination.

  1983cited by this paper
• A controlled comparison of aspirin and oral anticoagulants in prevention of death after myocardial infarction.

  1982cited by this paper
• A 7-year analysis of haemorrhage in patients on long-term anticoagulant treatment.

  1979cited by this paper
• Management of anticoagulation in outpatients: experience with an anticoagulation service in a municipal hospital setting.

  1977cited by this paper
• Assessment of older people: self-maintaining and instrumental activities of daily living.

  1969cited by this paper
• EPIDEMICS OF TYPHOID FEVER.

  1964cited by this paper
• STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.

  1963cited by this paper
• Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial.

  1960cited by this paper

• Management of Acenocoumarol in Tunisian elderly population : Risk factors of overdose and bleeding

  2025cites this paper
• Correlation between Metabolic Parameters and Warfarin Dose in Patients with Heart Valve Replacement of Different Genotypes

  2024cites this paper
• Nine-Year Trends in Prevention of Thromboembolic Complications in Elderly Patients with Atrial Fibrillation Treated with NOACs

  2022cites this paper
• When to anticoagulate, and which anticoagulant?

  2022cites this paper
• Green Pit Viper Envenomations in Bangkok: A Comparison of Follow-Up Compliance and Clinical Outcomes in Older and Younger Adults

  2022cites this paper
• Organ-differential Roles of Akt/FoxOs Axis as a Key Metabolic Modulator during Aging

  2021cites this paper
• Predictors of Over-Anticoagulation in Warfarin Users in the UK General Population: A Nested Case–Control Study in a Primary Health Care Database

  2018cites this paper
• NOVEL ANTICOAGULANTS BEYOND HEPARIN AND WARFARIN

  2018cites this paper
• Anticoagulación oral en el adulto mayor frágil con fibrilación auricular

  2017influential citation
• Molecular and physiological manifestations and measurement of aging in humans

  2017cites this paper
• Study of environmental and genetic factors determining warfarin toxicity

  2017cites this paper
• Modification des traitements de l’arythmie cardiaque par fibrillation auriculaire chez les personnes âgées suite à une hospitalisation dans le service de gériatrie du CHU de Nancy: faits et mythes

  2015cites this paper
• Factors influencing warfarin response in hospitalized patients

  2015cites this paper
• Les anticoagulants oraux : source inépuisable d’événements iatrogènes médicamenteux

  2014cites this paper
• Différenciation génétique des populations humaines pour les gènes de la réponse aux médicaments

  2014cites this paper
• [Risk factors of serious bleeding among ambulatory patients taking antivitamin K aged 75 and over].

  2014cites this paper
• Évaluation de l'équilibre des AVK en post-hospitalisation chez des sujets âgés traités pour une FA : FAREMBOL-AMBU 1re partie. Étude rétrospective sur un territoire géographique déterminé de la région Aquitaine

  2014influential citation
• Benefit of Warfarin Compared With Aspirin in Patients With Heart Failure in Sinus Rhythm: A Subgroup Analysis of WARCEF, a Randomized Controlled Trial

  2013cites this paper
• Use of Vitamin K Antagonist Therapy in Geriatrics: A French National Survey from the French Society of Geriatrics and Gerontology (SFGG)

  2013cites this paper
• Gestion des anticoagulants oraux au domicile par les patients âgés

  2013cites this paper
• Étude des facteurs responsables du déséquilibre des anti-vitamines K dans les Alpes-Maritimes : étude prospective à partir de 64 cas

  2013cites this paper
• Mechanical circulatory support for elderly heart failure patients

  2012cites this paper
• Anticoagulation par antivitamines K: analyse des interactions médicamenteuses et des polymorphismes génétiques à l'origine de la variabilité de la réponse et des risques liés à l'acénocoumarol

  2012cites this paper
• Factor VII Levels and International Normalized Ratios in the Early Phase of Warfarin Therapy

  2010influential citation
• Particularité des traitements anticoagulants et de leur surveillance en gériatrie

  2007cites this paper
• Consultation de pharmacie et niveau de connaissance des patients hospitalisés traités par des médicaments anti-vitamine K

  2006cites this paper
• [Pharmaceutical counselling and evaluation of the knowledge of hospitalized patients treated with anti-vitamin K drugs].

  2006cites this paper
• Warfarin Monitoring in Ambulatory Older Individuals Receiving Antimicrobial Therapy

  2005cites this paper
• Upsetting the apple cart: a community anticoagulation clinic survey of life event factors that undermine safe therapy.

  2005cites this paper
• To develop and trial a new warfarin education program

  2005cites this paper
• Anticoagulant treatment at a specialized outpatient anticoagulant therapy unit, a descriptive study

  2005cites this paper
• FACULTE DE MEDECINE DE BOBIGNY

  2005cites this paper
• [Cytochrome P450 2C9 polymorphisms (CYP2C9) and warfarin maintenance dose in elderly patients].

  2004cites this paper
• Polymorphismes du cytochrome P450 2C9 (CYP2C9) et posologie à l’équilibre pour des patients âgés traités par warfarine

  2003cites this paper
• [Anticoagulant clinic: a tool for reducing bleeding complications of oral anticoagulant treatment].

  2003cites this paper
• Les centres de suivi et de conseil des traitements anticoagulants: un outil pour diminuer le nombre de complications hémorragiques des antivitamines K

  2003cites this paper